A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/2004
12/23/2004	WO2004110151A1 Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
12/23/2004	WO2004089471A3 NEW PYRAZOLO[1,5-a] PYRIMIDINES DERIVATIVES AND PHARMACEUTICAL USE THEREOF
12/23/2004	WO2004089470A3 New amide derivatives and pharmaceutical use thereof
12/23/2004	WO2004089380A3 Pharmaceutical use of fused 1,2,4-triazoles
12/23/2004	WO2004084881B1 METHODS FOR TREATING FUNCTIONAL BOWEL DISORDERS USING α2δ SUBUNIT CALCIUM CHANNEL MODULATORS WITH SMOOTH MUSCLE MODULATORS
12/23/2004	WO2004084876A3 Use of compounds for the prevention of drug-induced cell toxicity
12/23/2004	WO2004082674A9 Carnitine retention
12/23/2004	WO2004082588A3 Dispersible formulation of an anti-inflammatory agent
12/23/2004	WO2004082586A3 Phamaceutical compositions comprising inhibitors of fab i and further antibiotics
12/23/2004	WO2004071429A3 Lung inflammation treatment
12/23/2004	WO2004064715A3 Polyhydroxylated pyrrolizidine
12/23/2004	WO2004054497A3 Use of a trpm8-activating substance for the treatment of tumours
12/23/2004	WO2004037199A3 Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain
12/23/2004	WO2003089002A9 Fp receptor antagonists or pgf2 alpha antagonists for treating menorrhagia
12/23/2004	WO2003083436A3 Fibrinogen binding moieties
12/23/2004	WO2003082198A3 Methods of treatment with lxr modulators
12/23/2004	WO2003076569A3 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
12/23/2004	WO2003037167A3 Pathway of rantes-mediated chemokine synthesis in astrocytes and methods of use therefor
12/23/2004	US20040260268 Drug/drug delivery systems for the prevention and treatment of vascular disease
12/23/2004	US20040260098 Synthesis of epothilones, intermediates thereto and analogues thereof
12/23/2004	US20040259948 Liver receptors as antiinflammatory agents and for immunity with administering agonist
12/23/2004	US20040259945 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies
12/23/2004	US20040259941 Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
12/23/2004	US20040259936 Patients in need of anticancer treatment or treatment of lymphomas or autoimmune disease
12/23/2004	US20040259932 Method and compound to reduce the incidence of diabetes in a subject with chronic heart failure
12/23/2004	US20040259920 Acne treatment
12/23/2004	US20040259918 treatment of diabetes mellitus with compounds of given formula such as sulfonamides and an antidiabetic agent such as sulfonylureas, biguanides, glitazones, alpha-glucosidase inhibitors, glucagon antagonists
12/23/2004	US20040259917 Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
12/23/2004	US20040259909 using an agonist of alpha 7 nicotinic acetylcholine receptors rather than those of 5HT3 receptors; tropisetron; spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidine-2'-one; N-(1-azabicyclo[2.2.2]oct-3-yl)(3-phenylbenzamide); N-(nitrogen heterocycle)-carboxamides or thiocarboxamides
12/23/2004	US20040259899 in patients who are refractory to laxative and stool softener treatment, such as cancer patients on opioids such as morphine, using an opioid antagonist such as methylnaltrexone and a laxative and/or stool softener
12/23/2004	US20040259893 Use of tyrosine kinase inhibitions for treating allergic diseases
12/23/2004	US20040259892 c-kit inhibitor; unable to promote death of IL-3 dependent cells cultured in presence of IL-3; N-phenyl-2-pyrimidine-amine derivatives; 4-(4-methylpiperazine-1-ylmethyl)-N-[4-methyl-3-(4-pyridine-3-yl)pyrimidine-2 ylamino)phenyl]-benzamide
12/23/2004	US20040259889 Vasconstriction ; administering adenosine receptor antagonist
12/23/2004	US20040259886 Compositions and methods for treating osteoporosis and lowering cholesterol
12/23/2004	US20040259876 Bicyclic compound, production and use thereof
12/23/2004	US20040259863 Type 4 phosphodiesterase inhibitors and uses thereof
12/23/2004	US20040259862 Method of treating functional bowel disorders
12/23/2004	US20040259858 such as 3-(2-methyl-4-pyrrolidin-1-yl-quinolin-7-yl-methoxy)-benzonitrile; neuropeptide y receptor antagonists; for treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity
12/23/2004	US20040259855 Methods and devices for epithelial protection during photodynamic therapy
12/23/2004	US20040259854 Methods and devices for epithelial protection during photodynamic therapy
12/23/2004	US20040259850 Method for treating or preventing symptoms of hormonal variation including hot flashes
12/23/2004	US20040259840 Using phosphoglycerides, lipid having sphingosine base, glycerides and sterol; wound healing agents; atherosclerosis
12/23/2004	US20040259832 Synergistic mixture of thymidine kinase inhibitor and viricides
12/23/2004	US20040259829 Carboxylesterase; antitumor agents; drug screening; bioassay
12/23/2004	US20040259822 Antibody which recognizes epitope containing nucleic acid coupled to active protein; hybridomas
12/23/2004	US20040259821 In nonaqueous solvent; therapy for blood disorders; anticancer agents
12/23/2004	US20040259820 Kit for delivering decitabine in vivo
12/23/2004	US20040259817 Methods and formulations for the treatment of female sexual dysfunction
12/23/2004	US20040259816 Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive oxygen species and methods of using thereof
12/23/2004	US20040259815 Synergistic mixture containing tyrosine kinase inhibitor with carotenoils, flavonoids, apigenin
12/23/2004	US20040259798 Drugs; integrin antagonist; antiinflammatory agents; leukemia therapy
12/23/2004	US20040259795 Reducing sepsis; binding polypeptide to monoclonal antibody ; intensify gene expression; wound healing agents
12/23/2004	US20040259793 Methods and compositions for modulating proteins modified in preconditioning against ischemia/hypoxia
12/23/2004	US20040259792 Inhibitors of phosphodiesterases in infertility
12/23/2004	US20040259788 Use of neurotoxin therapy for treatment of urologic and related disorders
12/23/2004	US20040259787 C1q and collectin receptor
12/23/2004	US20040259767 Antiproliferative agents; therapy for human progessive leukoencephalophy ; suppression of dna viruses; anticancer agents
12/23/2004	US20040259765 Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis
12/23/2004	US20040259248 RNA interference mediating small RNA molecules
12/23/2004	US20040259247 short interfering RNAs for use treating diseases, in protein separation or purification, in drug screening; cell with target gene-specific knockout phenotype; double stranded RNA; RNA fragments are the sequence-specific mediators of RNAi (RNA interference)
12/23/2004	US20040259245 Complete nutrient medium for use as a cosmetic and cosmetic use thereof
12/23/2004	US20040259171 P2Y4 antibody and methods of use
12/23/2004	US20040259159 Role of LDL receptor protein-1 (LRP-1) in Alzheimer's disease
12/23/2004	US20040259103 NKR (Natural Killer Receptor); rapidly analyze physiological and pathological situations linked to these repertoires; use in diagnosise/prognosis of patients for transplant acceptance, resistance to infections and disease, and in drug screening for autoimmune diseases, antitumor agents, and antibiotics
12/23/2004	US20040259084 Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors
12/23/2004	US20040258772 Methods of treating angiogenesis, tumor growth, and metastasis
12/23/2004	US20040258771 Reduced toxicity cisplatin formulations and methods for using the same
12/23/2004	US20040258770 1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine, a platinum compound, an antineoplastic antimetabolic agent and folinic acid; colorectal cancer
12/23/2004	US20040258769 Use of ocular vitamins in conjunction with other treatment methods for AMD
12/23/2004	US20040258748 Compressing mixture of drug and effervescent acid source and base to produce a tablet; moisture activation; disintegration; drugs such as rofecoxib, simvastatin, olanzapine; and sodium bicarbonate
12/23/2004	US20040258745 Pharmaceutical composition containing artificial oxygen carrier
12/23/2004	US20040258734 Cranberry seed oil extract and compositions containing components thereof
12/23/2004	US20040258728 Delivery of drug coated stent; administered systemically; antiinflammatory and antiproliferative agents
12/23/2004	US20040258717 Cosmetic and dermatological preparations containing creatine for treating and actively preventing dry skin and other negative alterations of the physiological homeostasis of the healthy-skin
12/23/2004	US20040258708 Cytotoxic T-cell epitopes of papillomavirus L1 protein and their use in diagnostics and therapy
12/23/2004	US20040258698 Delivery of immune response modifier compounds
12/23/2004	US20040258691 Treating psoriasis in a patient by administering a therapeutically effective amount of an antibody immunospecific for vetronectin receptor av beta 3; antiinflammatory agents; antibody does not immunoreact with integrins other than av beta 3; cell adhesion
12/23/2004	US20040258674 Food or beverage formulation for improving cardiovascular health
12/23/2004	US20040258670 Introducing enriched human endothelial generating cells and mesenchymal stem cells; enhancing vasculogenesis and collateralization around blocked and/or narrowed vessels
12/23/2004	US20040255956 Post-conditioning for the reduction of ischemic-reperfusion injury in the heart and other organs
12/23/2004	CA2529225A1 Pharmaceutical composition and method for alleviating side effects of estrogen replacement therapy
12/23/2004	CA2528883A1 Pharmaceutical compositions for preventing or treating th1-mediated immune diseases
12/23/2004	CA2528863A1 Combined doses
12/23/2004	CA2528359A1 Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
12/23/2004	CA2527856A1 Substituted 1, 4-di-piperidin-4-yl-piperazine derivative combined with an opioid analgesic and their use for the treatment of pain and side-effects associated with opioid-based treatments
12/23/2004	CA2527368A1 Pharmaceutical composition
12/23/2004	CA2520148A1 Compositions and methods for treating coronavirus infection and sars
12/23/2004	CA2519875A1 Method of tumor regression with vegf inhibitors
12/22/2004	EP1489170A1 Transporter selectively transporting sulfate conjugate and its gene
12/22/2004	EP1489169A1 Sumo inhibitors
12/22/2004	EP1488809A1 Pharmaceutical combination containing a 4-quinazolineamine and another anti-neoplastic agent for the treatment of cancer
12/22/2004	EP1488808A1 Remedies for glomerular diseases
12/22/2004	EP1488807A1 Remedies for sex hormone-dependent disease
12/22/2004	EP1488795A1 Remedies for lung cancer
12/22/2004	EP1488789A1 Eye drops containing tetrazole derivative
12/22/2004	EP1488788A1 Pharmaceutical combinations and their use in treating gastrointestinal disorders
12/22/2004	EP1488761A1 Device for delivering a therapeutic agent to a blood vessel
12/22/2004	EP1488239A2 Methods and compositions for the identification, assessment, and therapy of small cell lung cancer
12/22/2004	EP1488231A2 Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof
12/22/2004	EP1487991A2 Cancer-linked gene as target for chemotherapy

1 ... 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 ... 1151